FDA Inspection 1162453 — Tomasz Huzarski, MD, PhD
The FDA completed an inspection of Tomasz Huzarski, MD, PhD on Jan 27, 2022 in Dobra (Szczecinska). The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 27, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dobra (Szczecinska) (Poland)
Additional Details
Clinical Investigator (CI)